HRR - Task - Cardiovascular responses to simulated spaceflight: molecular signatures and surrogate outputs to measure CVD risk.

NASA Logo Human Research Roadmap HRP Exploration Data

Evidence Risks Gaps Tasks Reports

Explore Search

- CV1
  - Arrhythmia
- CV8
  - Arrhythmia
- CVD-102
  - CVD
- CVD-103
  - CVD
- Degen - 2
  - CVD
  - Degen
- Degen - 3
  - CVD
  - Degen
- Degen - 7
  - CVD
  - Degen
- IM-101
  - Immune

Cardiovascular responses to simulated spaceflight: molecular signatures and surrogate outputs to measure CVD risk.

Last Published: 11/23/20 11:55:12 AM (Central)

Task Book: Entry Unavailable
Principal Investigator: Tahimic, Candice

Short Title: Cardiovascular responses to simulated spaceflight

Responsible HRP Element: Space Radiation

Collaborating Org(s):

Human Health Countermeasures (HHC) Element

Funding Status: Active - Currently funded and in progress

Procurement Mechanism(s):

Solicited

Aims:
Aim 1. Determine radiation dose-dependence of measures of cardiovascular performance in crew age-matched female and male mice in an acute ‘five-ion GCR simulation’ exposure model.
Aim 2. Determine effects of acute ‘five-ion GCR simulation’ exposure singly and in combination with simulated microgravity on cardiovascular performance measures in crew age-matched male and female mice, mimicking deep space missions.
Aim 3. Determine whether cardiovascular changes induced by GCR or in combination with HU correlate with specific and measurable behavioral, neuromotor and immune outcomes.

Resources (Other)

Deliverables (1)

Category: Risk Characterization, Quantification
Subcategory:

Description:
Study results may enable risk characterization.

Internal Customers:
Human Health Countermeasures
Space Radiation
External Customers:
None

Mappings

Risk of Adverse Health Event Due to Altered Immune Response

IM-101: Evaluate the effects of deep-space radiation on immune dysfunction, as an additional hazard to the effects of psychophysiological stress and weightlessness.

Cardiovascular responses to simulated spaceflight: molecular signatures and surrogate outputs to measure CVD risk.

Risk of Spaceflight Induced Cardiovascular Disease

CVD-102: Determine whether space radiation induces cardiovascular structural and functional changes and/or oxidative stress & damage (OSaD)/inflammation, that can contribute to development of disease.

CVD-103: Determine whether the combined effects of relevant deep-space radiation and weightlessness induce additive or synergistic effects on the cardiovascular system, and whether it is of concern for development of disease.

Cardiovascular responses to simulated spaceflight: molecular signatures and surrogate outputs to measure CVD risk.

Related Tasks (156)

Print View...

PRRs (4)

NASA Developer: Daniel Febus Responsible NASA Official: Susan Torney Contact HRP for a 508 compliant PDF Budgets, Strategic Plans, and Accountability Reports Equal Employment Opportunity Data Posted Pursuant to the No Fear Act Information-Dissemination Policies and Inventories Freedom of Information Act President's Management Agenda Privacy Policy & Important Notices Inspector General Hotline Contact HRP Human Health and Performance DIR Johnson Space Center USA.gov ExpectMore.gov

Common Item(s)
	Risk of Adverse Health Event Due to Altered Immune Response
	IM-101: Evaluate the effects of deep-space radiation on immune dysfunction, as an additional hazard to the effects of psychophysiological stress and weightlessness.